Position in OCUL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$175,904
-$76,219 QoQ
Shares Held
20,768
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EMERALD ADVISERS, LLC holds $600,984,884 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
1,600,886 | $90,946,333 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
748,325 | $65,066,858 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,603,319 | $62,048,445 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
468,295 | $54,823,295 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
567,430 | $50,376,435 | |
| 6 | CYTK |
Cytokinetics Inc
|
457,956 | $39,013,271 | |
| 7 | MANE |
Veradermics, Inc
|
288,370 | $35,452,207 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
229,486 | $35,070,050 |
All Filings in OCUL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $175,904 | 20,768 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $252,123 | 20,768 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $242,777 | 20,768 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $192,727 | 20,768 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $152,229 | 20,768 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $177,358 | 20,768 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $180,681 | 20,768 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $142,053 | 20,768 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $188,988 | 20,768 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $92,625 | 20,768 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $65,211 | 20,768 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $235,899 | 45,717 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $240,928 | 45,717 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,712,327 | 965,241 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $6,251,792 | 1,506,456 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $5,892,122 | 1,465,702 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $6,394,929 | 1,291,905 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $7,372,357 | 1,057,727 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $8,496,000 | 849,600 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $17,349,230 | 1,223,500 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $21,248,488 | 1,294,850 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $24,647,552 | 1,190,703 | Shares | Sole | 2021-01-29 | |
| No filing history on record for this holder in this stock. | ||||||